Brain Metastases — Comparison of Gadodiamide Injection-Enhanced MR Imaging at Standard and High Dose, Contrast-Enhanced CT and Non-Contrast-Enhanced MR Imaging

References

• Brasch R. C., Bennett H. F. Considerations in the choice of contrast media for MR imaging. Radiology 1988; 166: 897
   Google Scholar
• Cacheris W. P., Quay S. C., Rocklage S. M. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn. Reson. Imaging 1990; 8: 467
   PubMed Web of Science ®Google Scholar
• Davis P. C., Hudgins P. A., Peterman S. B., Hoffman J. C. Diagnosis of cerebral metastases. Double-dose delayed CT vs contrast-enhanced MR imaging. AJNR 1991; 12: 293, AJR 156 (1991)
   PubMed Web of Science ®Google Scholar
• Galicich J. H., Sundaresan N. Metastatic brain tumors. Neurosurgery, R. H. Wilkins, S. S. Rengachary. McGraw-Hill, New York 1985; 604
   Google Scholar
• Galicich J. H., Sundaresan N., Thaler H. T. Surgical treatment of single brain metastasis. Evaluation of results by computerized tomography scanning. J. Neurosurg. 1980; 53: 63
   PubMed Web of Science ®Google Scholar
• Greco A., McNamara M. T., Lanthiex P., Quay S. C., Michelozzi G. Gadodiamide injection. Nonionic gadolinium chelate for MR imaging of the brain and spine — phase II—III clinical trial. Radiology 1990; 176: 451
   Google Scholar
• Haugen I., Bach-Gansmo T., Øksendal A., et al. Comparison of Gadodiamide injection (S-041), a new nonionic gadolinium complex, with Dotarem and Magnevist in MR imaging of lesions in the central nervous system. J. Magn. Reson. Imaging 1991, Suppl. 1: 186, (P)
   Google Scholar
• Haughton V. M., Rimm A. A., Sobocinski K. A., et al. A blinded clinical comparison of MR imaging and CT in neuroradiology. Radiology 1986; 160: 751
   PubMedGoogle Scholar
• Haustein J., Laniado M., Niendorf H.-P., et al. Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors. Dosage and field strength. AJNR 1992; 13: 1199
   PubMed Web of Science ®Google Scholar
• Haustein J., Laniado M., Niendorf H.-P., et al. Triple-dose versus standard-dose gadopentetate dimeglumine. A randomized study in 199 patients. Radiology 1993; 186: 855
   PubMed Web of Science ®Google Scholar
• Healy M. E., Hesselink J. R., Press G. A., Middleton M. S. Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 1987; 165: 619
   PubMed Web of Science ®Google Scholar
• Myhr G., Rinck P. A., Börseth A. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS. Acta Radiol. 1992; 33: 405
   Google Scholar
• Parizel P. M., Degryse H. R., Gheuens J., et al. Gadolinium-DOTA enhanced MR imaging of intracranial lesions. J. Cornput. Assist. Tomogr. 1989; 13: 378
   Google Scholar
• Patchell R. A., Tibbs P. A., Walsh J. W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 1990; 322: 494
   PubMed Web of Science ®Google Scholar
• Runge V. M., Kirsch J. E., Burke V. J., et al. High-dose gadoteridol in MR imaging of intracranial neoplasms. J. Magn. Reson. Imaging 1992; 2: 9
   PubMed Web of Science ®Google Scholar
• Russell E. J., Geremia G. K., Johnson C. E., et al. Multiple cerebral metastases. Detectability with Gd-DTPA-enhanced MR imaging. Radiology 1987; 165: 609
   PubMed Web of Science ®Google Scholar
• Schubeus P., Schorner W., Haustein J., et al. Optimization of gadolinium-DTPA dose. An inter-individual study of patients with intracranial tumors. RöFO 1990; 153: 29
   Google Scholar
• Svaland M., Börseth A., Haugen I., et al. Safety aspects of Gadodiamide injection in MRI of the CNS. A comparison of 0.1 versus 0.3 mmol/kg body weight in six double-blind trials. (Abstract.). Eur. Soc. Magn. Reson. Med. Biol. 10th Annual Scientific Meeting, Rome, 1993
   Google Scholar
• Sze G., Brant-Zawadzki M., Haughton V. M., et al. Multicenter study of Gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991; 181: 693
   PubMed Web of Science ®Google Scholar
• Sze G., Milano E., Johnson C., Heier L. Detection of brain metastases. Comparison of contrast-enhanced MR with unen-hanced MR and enhanced CT. AJNR 1990; 11: 785
   PubMed Web of Science ®Google Scholar
• Sze G., Shin J., Krol G., Johnson C., Liu D., Deck M. D. F. Intraparenchymal brain metastases. MR imaging versus contrast-enhanced CT. Radiology 1988; 168: 187
   PubMed Web of Science ®Google Scholar
• Van Wagoner M., O'Toole M., Worah D., Leese P. T., Quay S. C. A phase I clinical trial with Gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent. Invest. Radiol. 1991; 26: 980
   Google Scholar
• Wedeking P., Kumar K., Tweedle M. F. Dissociation of gadolinium chelatis in mice. Relationship to chemical characteristics. Magn. Reson. Imaging 1992; 10: 641
   Google Scholar
• Weinmann H. J., Press W. R., Platzek J., Radüchel B. Tolerance of new contrast agents for MRI. Invest. Radiol. 1990, Suppl. 1: 49
   Google Scholar
• Yuh W. T. C., Engelken J. D., Muhonen M. G., Mayr N. A., Fisher D. J., Ehrhardt J. C. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR 1992; 13: 335
   PubMed Web of Science ®Google Scholar
• Yuh W. T. C., Fisher D. J., Engelken J. D., et al. MR evaluation of CNS tumors. Dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 1991; 180: 485
   Google Scholar